# Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension

> **NCT03091881** · PHASE4 · COMPLETED · sponsor: **Suez Canal University** · enrollment: 68 (actual)

## Conditions studied

- Spinal-induced Hypotension

## Interventions

- **DRUG:** Granisetron 0.1 MG/ML
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03091881
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091881, "Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03091881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*